Prevalence and Possible Predictors of Helicobacter Pylori Infection Among Adult Patients with Sickle Cell Disease in Ahmadu Bello University Teaching Hospital North-West, Nigeria

尼日利亚西北部阿赫马杜·贝洛大学教学医院成年镰状细胞病患者幽门螺杆菌感染的流行率及可能预测因素

阅读:2

Abstract

BACKGROUND: Helicobacter Pylori (H. pylori) infection occurs worldwide. Patients with Sickle Cell Disease (SCD) may present with abdominal symptoms due to different pathophysiological mechanisms. SCD patients are predisposed to infections due to immune deficiency, abdominal symptoms like dyspepsia and recurrent abdominal pain have been associated with H. pylori infection. This study determined H. pylori prevalence in adult SCA patients and its relationship with socio-demographic, clinical, and laboratory parameters. METHODOLOGY: Adult patients with SCA in Steady State were enrolled after informed consent. Sociodemographic, clinical, and laboratory parameters were documented using a structured questionnaire. H. pylori IgG antibody was detected using lateral flow Rapid Diagnostic Test (FaStep USA). Data were analyzed using EpiInfo 7.2. RESULTS: The median age of participants was 23(20, 26) years. Most of the participants (56.8%) were from lower socioeconomic classes. Sickle cell painful vaso-occlusive crises and blood transfusion in the previous 12 months were 2(1, 4) and 0(0, 1) respectively. Ninety (53.3%) of the participants had abdominal symptoms. Non-specific abdominal pain was the most common. The median frequency of abdominal pains was 1(0, 2). H pylori infection was found in 23.1%. The Odds for H. Pylori infection was high in participants with abdominal symptoms, antacid use, and multiple abdominal symptoms {OR=1.552, 1.306, and 2.584 respectively) though not statistically significant. At the same time those with recurrent abdominal pain and male sex had lower Odds (OR=0.875 and 0.831respectively), though not statistically significant. CONCLUSION: H. pylori infection is not uncommon among SCA patients. Physicians should be vigilant in SCD patients with multiple abdominal symptoms by screening early and instituting management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。